Dr. Susan Combs Scott, MD at #PLCClive24 with an overview of #EGFR exon 20 mutant NSCLC, where amivantamab is our new first line standard (with chemotherapy) and #HER2 mutant NSCLC, where the HER2 ADC trastuzumab deruxtecan is the approved targeted option. MedscapeLIVE

ALK+ NSCLC best practices from Vincent Lam With 4 highly active TKIs available, we are moving toward ⬆️ precision 🎯to choose b/t them 1L and select for treatment intensification. Will we soon consider variants? 🧬 TLC Conference #TexasLung24 ALK Positive Johns Hopkins Thoracic Oncology

Join Drs. Susan Combs Scott, MD, Jamie Chaft, Brendon Stiles, and Dr. Julie Brahmer for 'Early-Stage Lung Cancer (Application)'. Starting at 3:00pm CST at #TexasLung24!

What a fun meeting TLC Conference! Thank you Stephen V Liu, MD and Tina Cascone for being amazing hosts and congrats 👏to our thoracic queens- Marina Garassino Heather Wakelee for a fabulous debate! This is easy to judge/there is no debate-a perfect score of 10 for the best conference!

Find yourself a mentor who dances with you and don’t let go. #SheforShe #WomeninThoracicOncology #lcsm #TexasLung24 Susan Combs Scott, MD Dr. Julie Brahmer Sidney Kimmel Comprehensive Cancer Center Hematology & Oncology Women Physicians Group—HOWPG #mentoringmatters

The best of the best!

These wonderful people 🤠🫁🩺 #TexasLung24 TLC Conference Brendon Stiles @esinghimd Dr. Estela Rodriguez Stephen V Liu, MD Joshua Reuss Narjust Florez, MD, FASCO Dr. Julie Brahmer Misty Dawn Shields Christine Lovly, MD, PhD Jason Porter Christian Rolfo Tigirlily Gold

If you’re in the DMV, Dr. Michael Conroy and I will be discussing updates in #NSCLC on May 16th at the #LungCancerSymposium. RSVP by May 9th: cancersupportcommunity.salsalabs.org/lung-cancer-sy… #LCSM Johns Hopkins Thoracic Oncology Johns Hopkins University MedStar Georgetown Georgetown Hematology/Oncology Fellowship Georgetown Lombardi Georgetown University

I am deeply grateful for the time and effort the Next Wave Investigators in Thoracic Oncology Faculty have invested in mentoring us this weekend! BioAscend This is a PRIME opportunity for career development!! Thank you, co-chairs Drs. Dr. Julie Brahmer & Suresh S. Ramalingam, MD, FASCO ⬇️

CM77T NEJM by Drs. Cascone M.Provencio Perioperative (chemo-nivo followed by adjuvant nivo) vs. neoadj chemo alone. Key image below, early days but new landmark analysis shows potential benefit from the adjuvant component for pts who have definitive surgery? #lcsm IASLC

Outcomes with first-line osimertinib in 37 pts with rare atypical #EGFR exon 19 or compound mutations in #JTOCRR JTO & JTO CRR from Dr. Susan Combs Scott, MD Tia Cheunkarndee. RR 76%, median PFS 13m, time to discontinuation 22m, mOS 36m. jtocrr.org/article/S2666-…

With FLAURAishing new frontline combination therapies for EGFR+ mNSCLC yet incomplete data—What to do NOW in clinic? 🆘 @DrSteveMartin & I share our thoughts for #ASCODailyNews 👇🏽 dailynews.ascopubs.org/do/deciding-be… ASCO OncoAlert #lcsm

My colleague Dr. Michael Conroy from Johns Hopkins Thoracic Oncology discussing #KN671 in addition to other neoadjuvant/perioperative studies at the #LungCancerSymposium with the #CancerSupportCommunity! #nsclc #lcsm Susan Combs Scott, MD Joshua Reuss

Very proud of the team! Helping define high risk EGFRm+ patients. #ASCO24 #LCSM

🚨 DC Cancer Community: Consider an exciting 🎥 event this week: A phycian-patient partnership became Mission-Driven Tech, a women’s health innovation powerhouse. @globalradonc Eve McDavid I look forward to patient perspectives and expert discussion. eventbrite.com/e/mission-driv…

🚨Why should we study circulating tumor DNA (ctDNA)?🧬 Discover how my research on #ctDNA aims to uncover cancer drivers, enable earlier diagnosis, and pave the way for new treatments 💉💊 ⁦Moffitt Cancer Center⁩ ⁦Moffitt Research⁩ #Womeninresearch #NSCLC #MoffittAmbassadors

🌟 Unlock new possibilities in #LungCancer #Research Submit your abstract by Sept 30 ➡ce.ceconcepts.com/EGFR24 Jill Feldman Zosia Piotrowska @egfrresisters Stephen V Liu, MD Helena Yu Mary Jo Fidler Christine Lovly, MD, PhD @CEC_onc #LCSM #EGFR #EGFRSummit

Congratulations to Dr. Julie Brahmer Dr. Julie Brahmer - this year’s Paul A. Bunn Jr. Scientific Award winner for lifetime achievement and we’re ready to celebrate at #WCLC24!

With the goal of addressing a key clinical question, which pts w lung cancer may benefit from adjuvant immunotherapy after neoadjuvant, today at #WCLC2024 we presented results of an exploratory individual pt level analysis of the #CM77T & #CM816 trials 1/

Best block party and lots of dancing through the 70s, 80s, 90s and 2000s at the IASLC 50th anniversary celebration! #WCLC24 Dr. Julie Brahmer Patrick Forde Jarushka Naidoo Susan Combs Scott, MD